AngioDynamics, Inc.

AngioDynamics provides medical devices for vascular access, surgery, peripheral vascular disease, and oncology globally. Their products include Auryon Atherectomy system for treating peripheral arterial disease. Thrombus management portfolio includes AlphaVac, thrombolytic catheters, and AngioVac circuit for extracorporeal circulatory support. They also offer NanoKnife IRE Ablation System for surgical ablation of soft tissue. Peripheral products include angiographic catheters, guidewires, drainage catheters, and micro-introducer kits. Additional products include drainage catheters, micro Access kits, VenaCure EVLT system, and Solero MTA System. The company was founded in 1988 and is headquartered in Latham, New York.

Overview

Sector

Medical Instruments & Supplies

Target Price

1.2 USD

Current Price

10.7 USD

Potential

-89%

Strengths

Price to book ratio (2.19) is lower than the sector mean (3.86).
The company has low debt. Net Debt to EBITDA Ratio is 0.13 and it is lower than the sector mean.
EV/EBITDA (3.08) is lower than the sector mean (47.53).
Strong EBITDA Margin of 50.17%.

Weaknesses

With a depreciation Potential of -89.33%, based on our fundamental analysis, it suggests the stock may be overvalued.
Analysts expect revenues to decline in the coming year.
The company have lower returns than the sector in which it operates. ROIC (0.00%) is significantly lower than the sector mean (8.23%).
EV/EBIT (100.00) is significantly higher than the sector mean.
The Price to Free Cash Flow ratio (100.00) is significantly higher than the sector mean.

Key Financial Data

Indicator	Value
PER	100.0
EV/EBITDA	3.0
Price/Free Cash Flow'	100.0
ROIC	-%
Net Debt/EBITDA	0.1